chrisvoncsefalvay/vaers-outcomes huggingface dataset:
whole left side of my body that is numb and tingly and cold.. even my arm; feet have stronger tingle and pain when she stand; having facial numbness; tingling on left side of face/ feet have stronger tingle and pain; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EW0169, Expiration date: Not reported), via an unspecified route of administration in left arm on 16Aug2021 at 09:00 (at the age of 34-years-old) as dose 1, single for COVID-19 immunization in a hospital. There was no patient's medical history reported. The patient was healthy and had known allergies to codeine and latex. There were no concomitant medications/any other medications received within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination and didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Twenty five minutes after the vaccination, the patient began to have facial numbness and tingling on the left side of the face on 16Aug2021 at 09:25. Two days later on 18Aug2021, the patient's feet have stronger tingle and pain when she standup and currently after 4 weeks in Sep2021, the patient's whole left side of the body was numb, tingly and cold even in her arm. These events resulted in doctor or healthcare professional office/clinic visit and disability or permanent damage. It was unknown if the patient received treatment for these events. The outcome of the events was not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.
Patient experienced rash and facial/mouth swelling approximately 5 minutes after receiving vaccine. Patient received Epinephrine 0.3 ml of 1 mg/ml solution IM, plus benadryl 50 mg p.o. Patient was transported to ED.
Had 1st dose 12/18/20, had 2nd dose 1/8/21. On 1/15/21 noticed right cervical lymph node swollen >5cm. After 3 biopsies , diagnosed with non Hodgkin's lymphoma 2/11/21
Headache at the "back of the skull" that occurred 2 hours after the vaccine and went away by the afternoon
Hives on wrist, ankle, face, neck, trunk (front and back) thighs, buttocks.  Began approx. 5 days after shot and ongoing.  Today is  15th day.  New spots every day, and the older spots are not going away or lessening in severity.  Extremely itchy.  Very little relief from over the counter medications (Benadryl, calamine lotion).  Beginning a course of steroids today.
No additional AE; Temperature excursion case for PROQUAD; The child received the vaccine while under temperature excursion; This spontaneous report has been received from a medical assisstant concerning an 18-month-old child of unknown gender and ethnicity. The patient's concurrent conditions, known allergies/reactions, medical history and concomitant medications were not reported.   On 22-SEP-2020, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD) (lot # S022104 with expiration date 12-JAN-2021) 0.5 milliliter (route of administration not reported) for prophylaxis; while under temperature excursion at -5.5 celsius degrees (C) during a time frame of 3 minutes. The vaccine had not been exposed to previous temperature excursions. The temperature excursion was called by data logger. No additional adverse event (AE) was reported.
Had immunization at 10 AM. At 2 PM, school nurse called reporting symptoms of wheezing, and feeling lump in throat. Advised to go to ER. ER report, said mild difficulty breathing and swallowing. Pt received SOLU-MEDROL and BENADRYL and PEPCID. Observed 3 hrs. Discharged on Prednisone and BENADRYL.
It was discovered after the vaccine was administered that the stopper in the syringe appears to have been "rolled up" and let vaccine escape behind the stopper. It was determined by the Immunizer that less than half of the vaccine was administered to the patient and after consulting, another dose was administered to the patient in the same arm.
Pt. called following day to report that he got very sick 4 hours after vaccine. He reported shakes, nausea, headache, & swollen tongue (underneath tongue) fever. Very ill.
Arrhythmia; Rapid Heartbeat the evening after the vaccination; I have since been diagnosed with Supraventricular tachycardia (SVT); This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 07Apr2021 as dose 2, single (Lot number: EW0151) at the age of 37 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EN6208), administration date: 10Mar2021, when the patient was 37-year-old, for COVID-19 immunization. The following information was reported: ARRHYTHMIA (medically significant) with onset 07Apr2021, outcome "not recovered"; SUPRAVENTRICULAR TACHYCARDIA (non-serious) with onset 07Apr2021, outcome "not recovered", described as "I have since been diagnosed with Supraventricular tachycardia (SVT)"; HEART RATE INCREASED (non-serious) with onset 07Apr2021, outcome "not recovered", described as "Rapid Heartbeat the evening after the vaccination". The events "arrhythmia", "rapid heartbeat the evening after the vaccination" and "i have since been diagnosed with supraventricular tachycardia (svt)" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Heart rate irregular: (07Apr2021) Rapid Heartbeat, notes: Rapid Heartbeat the evening after the vaccination.  Clinical course: Rapid Heartbeat the evening after the vaccination. she had since been diagnosed with Supraventricular tachycardia (SVT) and have had ongoing problems with rapid heart rate and arrhythmia. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, had the patient been tested for COVID-19.There was none known allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.   No follow-up attempts are possible. No further information is expected.
pt recv vax & 1 or 2 days later, devel pruritus-treated w/an unspecified steroid; the itching abated, but on discontinuation of the steroid, the itching returned;pt was put on DPH which made pt dysfunctional; pruritus has worsened;
Diarrhea following vaccine - immediate...till present. Low grade fever - climbed to 102 for few days. Very swollen glands. Change in behavior - foggy - lethargic - lack of interest. Not sleeping - (twitching in sleep). Loss of appetite - (lost more than 1 pound in 4 days). Full body measles rash (4 days) puffy cheeks/eyes, eyes photosensitive to sun, bright light. 1 month plus.
Extreme Fatigue, Muscle Pain, Stomach Pain, numbness, tingling in arms and legs, migraines. Visited several Dr.s and multiple tests, referred to facility in 2013.
Symptoms started around 7:00 PM. They consisted of body aches, chills, headache, temp of 102 at its peak, injection site pain.
Patient received vaccine inadvertently after published expiration date. Moderna Company analyzed lot 031L20A and advised vaccine maintained activity necessary to protect against covid 19 on day vaccine was administered,. Also patient did not call in to complain of adverse event.  This is administrative error without adverse event.
The patient is a 73-year-old male. I have known the patient for many years, previously serving as his primary care physician. He has multiple medical problems including coronary artery disease and chronic congestive heart failure. About 4 weeks ago, he received the annual influenza vaccine. He normally receives a split dose over 2 weeks but received the entire dose in 1 shot. Within 2 to 3 days, he started to develop severe weakness. He had some flu-like symptoms with malaise, muscle aches, and low-grade fever as well. Over the past 3 weeks, he has developed progressive generalized weakness. He got to the point he could barely stand from a seated position and is minimally ambulatory. He was started on a course of oral prednisone 1 week ago but stopped taking it because of anxiety and some hallucinosis. Today, he was so weak that his wife could not get him to stand. He also has had a productive cough of bloody and green-colored sputum. He has intermittently had a low-grade fever.
Fever developed day of immunisation- Monday 8-3-09. Felt ill on Tuesday. Swelling deltoid, redness and warmth decreased on Fri. Here in office Friday 8-7-09 redness and warmth 1 1/2 inch in diameter. Patient states improved.
2hrs following vaccination myalgias began, getting progressively worse, eventually severe, resolved 10/1/14.
Woke in am 10/27 with hard, red bump @ vaccine site on Lt thigh. Mild fever, fussy-taken to urgent care, diagnosed with ear infection started AMOXICILLIN, TYLENOL. In a.m. of 10/28 reaction had doubled in size-very inflamed with white area @ center of reaction. Fever present. Taken to ER-started on new antibiotic but advised could simply be a reaction to shot. 10/29-Infant walking on leg with no discomfort.
Pain in arm after first dose of Covid Vaccine; This is a spontaneous report from a contactable consumer (patient). A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0181), via an unspecified route of administration in left arm on 09Jul2021 at in-between 16:00 and 17:00 (at the age of 52-year-old) as dose 1, single for COVID-19 immunisation at pharmacy. Medical history included sleep apnoea from an unknown date and unknown if ongoing, GERD (gastrooesophageal reflux disease) from an unknown date and unknown if ongoing. Concomitant medications included modafinil taken for sleep apnoea syndrome, start and stop date were not reported; omeprazole (PROTONIX) taken twice a day for gastrooesophageal reflux disease, start and stop date were not reported. Unspecified cholesterol medication taken for cholesterol, start and stop date were not reported. Family medical history relevant included cancer and high blood pressure in family. The patient's mother has high cholesterol. On 09Jul2021, experienced pain in arm after the first dose of COVID vaccine it lasted for about a week. The adverse event was not resulted in emergency room and physician office. Caller stated that in between her two doses of the vaccine she had a urine test done and it was perfectly clean. The outcome of the event was reported as resolved on an unknown date in Jun2021.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101070481 Same patient, different drug, different event (split)
Redness on her left arm, and other parts of her body; Itchiness on her left arm; Pain at the injection site; Tenderness at the injection site; Inflammation at the injection site; This spontaneous case was reported by a nurse and describes the occurrence of ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site). At the time of the report, ERYTHEMA (Redness on her left arm, and other parts of her body), PRURITUS (Itchiness on her left arm), INJECTION SITE PAIN (Pain at the injection site), TENDERNESS (Tenderness at the injection site) and INJECTION SITE INFLAMMATION (Inflammation at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment and concomitant medications were reported.
Immediately after injection, she had itching to the left arm site. She waited 15 minutes, then nurse asked her to wait another 15 minutes. Seen by physician with itching still present and given Benadryl 25 mg orally and watched another 20 minutes with resolution of symptoms.
disrupted her quality of life; Body itching (disrupted quality of life)/that was very bothersome; This case was reported by a physician via sales rep and described the occurrence of generalized pruritus in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced generalized pruritus and impaired quality of life. On an unknown date, the outcome of the generalized pruritus was recovered/resolved and the outcome of the impaired quality of life was unknown.   The reporter considered the generalized pruritus and impaired quality of life to be related to Shingrix.     Additional Information: GSK Receipt Date: 23-SEP-2022 Reporter's comment: Physician had friend who received Shingrix first dose and experienced full body itching for 3 months that was very bothersome and disrupted her quality of life.  Physician also stated that the patient looked at all possible causes and could only conclude it was due to vaccination with Shingrix. The patient did see physician multiple tirne for evaluation and treatment.  The patient was afraid to get second dose of Shingrix and will not get second dose. The reporter consented to follow-up.
Information has been received from a health professional concerning a 3-year-old female with NKDA and no past medical history who on 03/19/2001 was vaccinated with Varicella virus vaccine live. There was nonconcomitant medication. On 03/25/2001, the child's grandmother reported that the child experienced a generalized red rash throughout her body. She was afebrile and no treatment was ordered. Unspecified medical attention  was sought. FOLLOW-UP information has been received from a registered nurse to clarify information in this report It was reported that the pt's sister received Varicella virus vaccine live after being exposed to the chicken pox in school. A few days later, she developed  chicken pox. it was noted that the patient and her mother  broke out in the chicken pox after the sister's rash. Additonal information has been requested.
Case number# PHEH2016US026223, is an initial report received from a consumer (patient) through phone call via a Patient Oriented Program on 11 Oct 2016. This report refers to a 68-year-old female patient. Historical condition included clostridium difficile infection. Past medication included antibiotics (unspecified). Current condition was not reported. The patient was polymedicated. The patient underwent knee replacement. The patient received COSENTYX injection for the treatment of an unknown indication from an unknown date in Jun 2016 at a dose of 300 mg, QW4 (injection NOS) and she was vaccinated with seasonal influenza vaccine (unknown manufacturer, batch number: not reported) on an unknown date (reported as Friday). The patient had last dose of COSENTYX 2 weeks ago. On 08 Oct 2016 (reported as since Saturday), the patient was not feeling well. The patient was taking care of 2 sick grandchildren last week. On an unknown date, the patient was feeling very tired and a lot of post nasal drip in her throat (upper-airway cough syndrome). The patient stated that she needs to be very careful with what types of antibiotics she takes because of the C Diff. She would be contacting her physician. Action taken with COSENTYX and seasonal influenza vaccine was unknown. The outcome of the event was unknown. The seriousness and causality of the events were not reported. The consent was not given to contact reporter.
felt like I had the flu; headache; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (felt like I had the flu), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 048B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Apr-2021, the patient experienced INFLUENZA (felt like I had the flu), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches). In April 2021, INFLUENZA (felt like I had the flu), HEADACHE (headache), CHILLS (chills) and MYALGIA (body aches) had resolved.            No relevant concomitant product were reported No treatment medication was provided
1st dose, tired about 5 HR after vaccine. Tired 2nd day after 1st dose.  2nd dose was 4 1/2hr ago, so far no symptoms. Bed rest.
symptoms now described as "COVID arm" swelling, pain and redness in addition to extreme heat to the touch.
devel incessant crying about 1 hr p/vax; crying lasted about 5 hrs, pt had sudden cessation of crying w/no recurrence through the next 23 hrs of in hosp observation; no apnea observed;
4-3-07 a few hrs after shot given-soreness got worse-Thursday 4-5 she felt very tired-slept 9 hrs when laid down for nap. Friday-redness and pain about 5: in diam. Reported on Mon 4-9 and states it is getting better. Not as painful or swollen did not seek treatment
Swelling, redness and induration with itching over right deltoid adjacent to site of injection.
Symptoms after 2nd dose:  swollen/red/hot arm. pain down arm and up into neck. continues at day 4 after dose,  body aches, riggors, malaise, tired for 2-3days after dose.   took Tylenol 100mg and IBU 600mg every 6hrs
A hot flush to my face turning my cheeks red, and I broke out in a cold sweat and my tongue felt a little tingly.  These symptoms lasted about 35 minutes and then I was fine. I?ve never been allergic to anything so my question is should I take the second dose, since I know it is much stronger what do you advise?
Breakthrough case admission after 2 vaccines  Moderna 3/2/21 lot# 023M20A;  Moderna 3/30/21 lot# 030a21A
Constipation; This is a spontaneous report from a contactable consumer. A 82-year-old male patient received first dose of bnt162b2 (BNT162B2; Solution for injection; Lot number: EN6201) via unspecified route of administration on Left arm on 11Feb2021 11:00 at single dose for covid-19 immunization. Medical history and concomitant medications were not reported. It was reported on 11Feb2021 patient experienced constipation and did not received any treatment. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient diagnosed with COVID-19 was unknown; Patient has not tested positive for COVID-19 since having the vaccine. The outcome of the event was "Recovered".
lt arm from shoulder to elbow-swelled, very red & very hot to touch; burning feeling inside the arm; This started a few hrs p/the shot; approx 10 hrs p/very severe h/a, which lasted about 48 hrs p/shot; tired no energy for a few days p/shot
For the last 3 days, fever of 100, chills, fatigue, nausea ,  bruising on arm at vaccination site
Mouth sores covering the roof of my mouth and cold sores on my lip lasting for 7 days.
Mother reports a pruritic rash that began on his face within hours of receiving the immunizations, the rash then spread to the remainder of his body. No other issues reported. Arrived 4/7/15 for treatment of the rash.
Patient received Moderna vaccine at 17 yrs and 8mths - Moderna approved for 18 years and older. Spoke with mother to ensure patient had no ill effects from receiving the vaccine before age 18. Mother reported patient was well and has had 3 Moderna vaccines and tolerated all with no side effects.
Moderna COVID?19 Vaccine EUA ?Covid arm?  redness, itchiness, hot to touch, and tender all at site of injection.  Roughly 2x2.5 inches.
Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 66-year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Flu" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Tiredness".  Additional information: Consumer calling to report side effects of the vaccine he had yesterday and says he didn't think it would be anything like this, the first dose he had almost no symptoms other than tiredness which was manageable.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I received the vaccine on Thursday and on Friday underneath my left arm (my armpit) began to swell up and throbbing consistently all the way through end of day Sunday.  The location was very hot and was dark where it was swollen
On 2/6/00, the pt experienced 50 small blisters on the trunk and a fever of 99.3. No complications were noted. This was reported as "modified chickenpox secondary to vaccine." There were no known contacts with chickenpox. No further information is available.
Mom reports observing child's right leg on 6/27/01, at which time, it was red and hot to touch. Mom stated she started range of motion to the right leg and gave Motrin, .4cc. No vomiting, fever or diarrhea observed. Today, mom in clinic and reports right leg (RLT) less tender, also states leg not as hot but appears more firm and hard.
The patient received the vaccine on April 7, 2021.  Almost immediately after the vaccine, the patient developed some nonspecific complaints of headache, myalgias, arthralgias, fever and chills.  The symptoms lasted for several days and then seemed to resolve. She was then at her baseline until approximately April 15, 2021 when she noted that she was becoming bruised.  She had multiple ecchymoses on her lower extremities and this has never happened to her before.  She apparently began taking aspirin at that time.  According to the patient, she took 325 mg of aspirin on April 15th, 16th, and 17th.  She did not take any aspirin on April 18th but then on April 19th, she took 650 mg of aspirin.  On April 19, she had a telehealth visit.  They recommended that she go to an urgent care.  She went to an urgent care on the afternoon of April 19.  They told her that they were ill equipped to take care of her and then sent her to the emergency department. On arrival in the ED on 04/20/21 she was afebrile.  O2 saturation was 99% on room air.  Her other vital signs were unremarkable.  Her initial laboratory studies were notable for white count of 6.6 with a hemoglobin 15.2.  Her initial platelet count was 5,000.  Initial chemistry panel was completely unremarkable.  She was not having any headache, dizziness, nausea, vomiting, blurred vision or any neurologic symptoms.  She thinks that her lower extremities are swollen.  She was not having any myalgias or arthralgias.  Not having any abdominal pain, nausea vomiting, diarrhea, dysuria, urgency, frequency.  . The patient has no other specific complaints.The patient was admitted on 04/20/21.
Sweats fever Was given 0.5 ml dose instead of 0.25 ml